Research for a cure to younger-onset Alzheimer’s … because it is far too early to write your final chapter.
The Bruce A. Pasternack Family Fund’s (BAPFF) mission is to support innovative, targeted research to uncover the causation, mitigation and treatment for younger-onset Alzheimer’s disease and similar dementia-related neurodegenerative diseases.
While Alzheimer’s is typically associated with the elderly population, 6% are diagnosed before age 65.
.Younger-onset (also called early-onset) Alzheimer's (Y-OAD) is an uncommon form of dementia that affects people younger than age 65. About 5% to 6% of people with Alzheimer's disease develop symptoms before age 65. So if 4 million Americans have Alzheimer's, around 200,000 to 240,000 people have the young-onset form of the disease. (Mayo Clinic, July 8, 2020)
We imagine a world where Alzheimer's, Vascular dementia, Lewy body dementia, Parkinson's, Frontotemporal, Creutzfeldt-Jakob, and other Neurodegenerative Diseases (NDDs) cease to exist. Join us to find a path forward.
Ready to join our journey?
Whether you love someone with Alzheimer’s disease, are on a personal Alzheimer’s journey, are seeking to learn more about younger-onset or just want to support efforts to find a cure, we welcome your investment of time, talent, and treasure.
Magic, mysticism, wishful thinking - even hope - won’t eliminate this affliction. Thus, in honor of the indomitable spirit of our namesake, Bruce A. Pasternack - who lost his fight against younger-onset Alzheimer’s at age 73 on January 13, 2021 - we are committed to working with the most innovative and talented medical researchers and practitioners to find a cure.
